Efavirenz Versus Rilpivirine on Vascular Function, Inflammation, and Oxidative Stress

This study is currently recruiting participants.
Verified March 2013 by Indiana University
Sponsor:
Collaborator:
Janssen Services, LLC
Information provided by (Responsible Party):
Samir Gupta, Indiana University
ClinicalTrials.gov Identifier:
NCT01585038
First received: April 23, 2012
Last updated: October 11, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2014
  Estimated Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)